Literature DB >> 20371314

Phospholemman modulates the gating of cardiac L-type calcium channels.

Xianming Wang1, Guofeng Gao, Kai Guo, Viktor Yarotskyy, Congxin Huang, Keith S Elmslie, Blaise Z Peterson.   

Abstract

Ca(2+) entry through L-type calcium channels (Ca(V)1.2) is critical in shaping the cardiac action potential and initiating cardiac contraction. Modulation of Ca(V)1.2 channel gating directly affects myocyte excitability and cardiac function. We have found that phospholemman (PLM), a member of the FXYD family and regulator of cardiac ion transport, coimmunoprecipitates with Ca(V)1.2 channels from guinea pig myocytes, which suggests PLM is an endogenous modulator. Cotransfection of PLM in HEK293 cells slowed Ca(V)1.2 current activation at voltages near the threshold for activation, slowed deactivation after long and strong depolarizing steps, enhanced the rate and magnitude of voltage-dependent inactivation (VDI), and slowed recovery from inactivation. However, Ca(2+)-dependent inactivation was not affected. Consistent with slower channel closing, PLM significantly increased Ca(2+) influx via Ca(V)1.2 channels during the repolarization phase of a human cardiac action potential waveform. Our results support PLM as an endogenous regulator of Ca(V)1.2 channel gating. The enhanced VDI induced by PLM may help protect the heart under conditions such as ischemia or tachycardia where the channels are depolarized for prolonged periods of time and could induce Ca(2+) overload. The time and voltage-dependent slowed deactivation could represent a gating shift that helps maintain Ca(2+) influx during the cardiac action potential waveform plateau phase. Copyright (c) 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371314      PMCID: PMC2849072          DOI: 10.1016/j.bpj.2009.11.032

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

1.  The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression.

Authors:  K J Sweadner; E Rael
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

2.  Effects of phospholemman downregulation on contractility and [Ca(2+)]i transients in adult rat cardiac myocytes.

Authors:  M Ayoub Mirza; Xue-Qian Zhang; Belinda A Ahlers; Anwer Qureshi; Lois L Carl; Jianliang Song; Amy L Tucker; J Paul Mounsey; J Randall Moorman; Lawrence I Rothblum; Thomas S Zhang; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-18       Impact factor: 4.733

Review 3.  Calcium channel blockers in the treatment of disease.

Authors:  Keith S Elmslie
Journal:  J Neurosci Res       Date:  2004-03-15       Impact factor: 4.164

4.  Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channels.

Authors:  X Y Wei; E Perez-Reyes; A E Lacerda; G Schuster; A M Brown; L Birnbaumer
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

Review 5.  Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists.

Authors:  R W Tsien; B P Bean; P Hess; J B Lansman; B Nilius; M C Nowycky
Journal:  J Mol Cell Cardiol       Date:  1986-07       Impact factor: 5.000

6.  Novel mechanism of voltage-dependent gating in L-type calcium channels.

Authors:  D Pietrobon; P Hess
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

7.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

8.  Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644.

Authors:  M C Nowycky; A P Fox; R W Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.

Authors:  Igor Splawski; Katherine W Timothy; Leah M Sharpe; Niels Decher; Pradeep Kumar; Raffaella Bloise; Carlo Napolitano; Peter J Schwartz; Robert M Joseph; Karen Condouris; Helen Tager-Flusberg; Silvia G Priori; Michael C Sanguinetti; Mark T Keating
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

10.  beta-Adrenergic stimulation modulates Ca2+- and voltage-dependent inactivation of L-type Ca2+ channel currents in guinea-pig ventricular myocytes.

Authors:  Ian Findlay
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

View more
  18 in total

1.  Amino acid substitutions in the FXYD motif enhance phospholemman-induced modulation of cardiac L-type calcium channels.

Authors:  Kai Guo; Xianming Wang; Guofeng Gao; Congxin Huang; Keith S Elmslie; Blaise Z Peterson
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-18       Impact factor: 4.249

2.  Residues 248-252 and 300-304 of the cardiac Na+/Ca2+ exchanger are involved in its regulation by phospholemman.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Angi M Ji; Tung O Chan; Joseph Y Cheung
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

3.  Induced overexpression of Na(+)/Ca(2+) exchanger does not aggravate myocardial dysfunction induced by transverse aortic constriction.

Authors:  Jufang Wang; Erhe Gao; Tung O Chan; Xue-Qian Zhang; Jianliang Song; Xiying Shang; Walter J Koch; Arthur M Feldman; Joseph Y Cheung
Journal:  J Card Fail       Date:  2013-01       Impact factor: 5.712

4.  Regulation of in vivo cardiac contractility by phospholemman: role of Na+/Ca2+ exchange.

Authors:  Jufang Wang; Erhe Gao; Joseph Rabinowitz; Jianliang Song; Xue-Qian Zhang; Walter J Koch; Amy L Tucker; Tung O Chan; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-30       Impact factor: 4.733

5.  Structure of the Na,K-ATPase regulatory protein FXYD2b in micelles: implications for membrane-water interfacial arginines.

Authors:  Xiao-Min Gong; Yi Ding; Jinghua Yu; Yong Yao; Francesca M Marassi
Journal:  Biochim Biophys Acta       Date:  2014-05-02

6.  Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality.

Authors:  M Ayoub Mirza; Susan Lane; Zequan Yang; Themis Karaoli; Kwame Akosah; John Hossack; Marcia McDuffie; JuFang Wang; Xue-Qian Zhang; Jianliang Song; Joseph Y Cheung; Amy L Tucker
Journal:  Clin Transl Sci       Date:  2012-03-27       Impact factor: 4.689

7.  Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.

Authors:  JuFang Wang; Jianliang Song; Erhe Gao; Xue-Qian Zhang; Tongda Gu; Daohai Yu; Walter J Koch; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-31       Impact factor: 4.733

8.  Constitutive overexpression of phosphomimetic phospholemman S68E mutant results in arrhythmias, early mortality, and heart failure: potential involvement of Na+/Ca2+ exchanger.

Authors:  Jianliang Song; Erhe Gao; Jufang Wang; Xue-Qian Zhang; Tung O Chan; Walter J Koch; Xiying Shang; Jeffrey I Joseph; Blaise Z Peterson; Arthur M Feldman; Joseph Y Cheung
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

Review 9.  Phospholemman: a novel cardiac stress protein.

Authors:  Joseph Y Cheung; Xue-Qian Zhang; Jianliang Song; Erhe Gao; Joseph E Rabinowitz; Tung O Chan; Jufang Wang
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

10.  Regulation of L-type calcium channel by phospholemman in cardiac myocytes.

Authors:  Xue-Qian Zhang; JuFang Wang; Jianliang Song; Joseph Rabinowitz; Xiongwen Chen; Steven R Houser; Blaise Z Peterson; Amy L Tucker; Arthur M Feldman; Joseph Y Cheung
Journal:  J Mol Cell Cardiol       Date:  2015-04-25       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.